Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a New Method to Detect CYP2D6 Poor Metabolizers by Monitoring Seric Concentrations of O-demethyl-tramadol and Tramadol to Make a Ratio in Comparison With Genotyping in Post-operative Patients Treated With Intravenous Tramadol

NCT00952159 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT00952159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00952159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a New Method to Detect CYP2D6 Poor Metabolizers by Monitoring Seric Concentrations of O-demethyl-tramadol and Tramadol to Make a Ratio in Comparison With Genotyping in Post-operative Patients Treated With Intravenous Tramadol
Lead sponsor
University Hospital, Caen
Phase
Observational
Overall status
Completed
Start date
April 30, 2010
Completion date
June 30, 2011
Enrollment
301 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

post-operative patients treated by tramadol